Roivant Sciences Ltd.

1. 01

   Ahead of SPY and its sector fund XLV over 1 year

   1 month: +7.6% (SPY −1.6%, XLV +13.5%). 3 months: +10.5% (SPY −0.4%, XLV +15.5%). 1 year: +92.4% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: ROIV, SPY and XLV · as of 4 Nov 2026

2. 02

   7.9 days to cover short interest

   40.3M shares were sold short at the 15 Oct 2026 settlement, 5.6% of the 722.3M shares outstanding; covering them would take 7.9 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

3. 03

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $38.23 was 4.3% above its 50-day average ($36.67) and 20.6% above its 200-day average ($31.71). It has closed above the 200-day for 335 sessions, since 9 Jul 2025. The 50-day average crossed above the 200-day on 23 Jul 2025, 324 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

4. 04

   81% of the way up its 52-week range

   Closed at $38.23 on 4 Nov 2026: 10.0% below the 52-week high of $42.50 (8 Sep 2026) and 93.2% above the low of $19.79 (10 Nov 2025).

   Daily price bars, split-adjusted · as of 4 Nov 2026

5. 05

   Volume 1.8× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 11.7M shares was 1.8× the average of the 30 sessions before it (6.5M), as the price rose 6.1%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

At the 4 Nov 2026 close